Hara / Hosokawa / Nishihara | Progranulin and Central Nervous System Disorders | Buch | 978-981-1361-88-3 | sack.de

Buch, Englisch, 183 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 300 g

Hara / Hosokawa / Nishihara

Progranulin and Central Nervous System Disorders

Buch, Englisch, 183 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 300 g

ISBN: 978-981-1361-88-3
Verlag: Springer Nature Singapore


This book presents the latest knowledge on the roles of progranulin (PGRN) in normal physiology and pathology and explores the emerging significance of PGRN as a therapeutic target and biomarker in various CNS disorders, including frontotemporal lobe degeneration and other neurodegenerative diseases. Following initial recognition of the importance of PGRN in sexual differentiation of the developing brain and adult neurogenesis, it was subsequently discovered that PGRN acts as a chaperone of lysosomal enzymes and plays a crucial role in maintaining cellular protein homeostasis. It has also been found that sex steroids modulate the expression of PGRN and its trophic effects in the developing CNS and that PGRN directly or indirectly influences neural stem and progenitor cells. Against this background, deeper understanding of the molecular and functional properties of PGRN would provide fresh impetus for the development of mechanism-based therapeutic approaches for multiple disorders. Medications targeting the recovery of lysosomal function appear to hold particular promise in patients with neurodegenerative diseases resulting from PGRN insufficiency. In examining multiple aspects of this fascinating field, the book will be of high value for researchers and graduate students.
Hara / Hosokawa / Nishihara Progranulin and Central Nervous System Disorders jetzt bestellen!

Zielgruppe


Research

Weitere Infos & Material


Chapter 1. Molecular and Functional Properties of Progranulin.- Chapter 2. Progranulin as a biomarker for neurodegenerative diseases.- Chapter 3. PGRN and FTLD.- Chapter 4. PGRN and neurodegenerative diseases other than FTLD.- Chapter 5. Progranulin Regulations of Lysosomal Homeostasis and its Involvement in Neurodegenerative Diseases.- Chapter 6. Molecular and Functional Properties of Progranulin.- Chapter 7. PGRN and neuroinflammation.- Chapter 8. Neural Stem/Progenitor Cells and Progranulin.- Chapter 9. Generation and phenotyping of progranulin-deficient mice.- Chapter 10. Pleiotropic protective effects of progranulin in the treatment of ischemic stroke.- Chapter 11. New therapeutic approaches against ocular diseases.


Hideaki Hara, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Japan

Masato Hosokawa, Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Japan

Shinsuke Nakamura, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Japan

Takayoshi Shimohata, Department of Neurology and Geriatrics, Gifu University Graduate School of Medicine, Japan

Masugi Nishihara, Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Japan


Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.